Microbiomes market size to grow by USD 891.94 million from 2022 to 2027: Growth driven by increasing prevalence of diseases - Technavio

NEW YORK, Jan. 11, 2023 /PRNewswire/ -- The microbiomes market is forecasted to grow by USD 891.94 million from 2022 to 2027. Moreover, the growth momentum will accelerate at a CAGR of 21.95% during the forecast period, according to Technavio. 4D pharma Plc, AOBiome LLC, BiomX Inc., DuPont de Nemours Inc., Eligo Bioscience, ENTEROME SA, Evelo Biosciences Inc., ExeGi Pharma, Ferring BV, MaaT Pharma, OraSure Technologies Inc., Osel Inc., Pendulum Therapeutics Inc., PureTech Health Plc, Qualigen Therapeutics Inc., Second Genome Therapeutics, Seres Therapeutics Inc., Synlogic Inc., Synthetic Biologics Inc., and YSOPIA Bioscience are some of the major market participants. To know about the vendor offerings, request a sample report.

Microbiomes market 2023-2027: Scope

The microbiomes market report also covers the following areas:

• Porter's five forces analysis
• Customer landscape
• Market trends

Microbiomes market 2023-2027: Drivers & challenges

The increasing prevalence of diseases is notably driving the market growth. Due to the rising occurrence of diseases, it is now more important to create a drug candidate that can effectively cure these illnesses while also lowering healthcare expenditures. Microbiome therapy can modulate the gut microbiome, which can significantly improve responses in many cancer treatments. In the treatment of diabetes and obesity, microbiome therapy can successfully control energy metabolism as well as glucose and lipid balance. Due to these advantages of microbiome therapeutics, their requirement for development and commercialization has increased, fueling the expansion of the worldwide microbiome market during the course of the forecast period.

However, the challenges related to manufacturing and formulation will hamper the market growth during the forecast period. Some of the difficulties vendors confront during manufacturing and formulation processes are making stable grafts, locating acceptable biosensors, producing robust genomes while maintaining safety and bio content standards, and efficiently constructing microbial medicines. The process is further complicated by the fact that there is little research on how to handle the culture required to produce microbiome-based medicinal and diagnostic products.

To know about the other drivers & challenges - Download a sample now!

Microbiomes market 2023-2027: Segmentation analysis

• Application Outlook (USD Million, 2017 - 2027)
• Therapeutics
• Diagnostics

• Product Outlook (USD Million, 2017 - 2027) 
• Probiotics
• Foods
• Prebiotics
• Medical food
• Others

• Region Outlook (USD Million, 2017 - 2027) 
• North America 
• The U.S.
• Canada
• Europe 
• The U.K.
• Germany
• France
• Rest of Europe
• Asia 
• China
• India
• Singapore
• Rest of World (ROW) 
• Brazil
• Argentina
• Rest of the Middle East & Africa

Microbiomes market 2023-2027: Segmentation highlights

• The Microbiomes market share growth by the therapeutics segment will be significant. Most therapeutic microbiome-based treatments under development aim to alter the gut microbiota using probiotics and prebiotics. The postbiotic approach, which concentrates on the creation of particular molecules and directly impacts the host, provides considerable potential and increased effectiveness in the treatment of a wide range of disorders. During the projection period, the development of such treatment strategies will result in the commercial availability of numerous microbiome-based medicinal products.
• 44% of the market's growth will account from North America during the forecast period. The US is a key market for microbiomes in North America. Market growth in this region will be faster than the growth of the market in Europe. The growing focus on microbiome-based clinical trials and the prevalence of gastrointestinal and non-gastrointestinal diseases will facilitate the microbiome market growth in North America over the forecast period.

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies, growth strategies, product innovations, new product launches, investments, and growth in market share, among others, Buy the Report.

Microbiomes market 2023-2027: Key highlights

What are the key data covered in this microbiomes market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the microbiomes market between 2022 and 2027
• Precise estimation of the size of the microbiomes market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the microbiomes market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of microbiomes market vendors

Gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

Related Reports:

• Medical Aesthetics Market by Type, End-user, and Geography - Forecast and Analysis 2023-2027: The medical aesthetics market is estimated to grow at a CAGR of 8.6% between 2022 and 2027. The size of the market is forecast to increase by USD 29.67 billion. The increasing global awareness about medical aesthetics is notably driving the market growth, although factors such as the high cost of treatment may impede the market growth.
• Digital Pathology Market by Product, Application and Geography - Forecast and Analysis 2023-2027: The digital pathology market is estimated to grow at a CAGR of 13.2% between 2022 and 2027. The size of the market is forecast to increase by USD 716.93 million. The growing adoption of IoT infrastructure among laboratories is notably driving the market growth, although factors such as issues regarding privacy and safety of a digital database may impede the market growth.

Browse for Technavio "Health Care" Research Reports

Table Of Contents :

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global microbiomes market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global microbiomes market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments 
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Therapeutics - Market size and forecast 2022-2027
• Exhibit 34: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)

• 6.4 Diagnostics - Market size and forecast 2022-2027
• Exhibit 38: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Application 
• Exhibit 42: Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments 
• Exhibit 43: Chart on Product - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 45: Chart on Comparison by Product
• Exhibit 46: Data Table on Comparison by Product

• 7.3 Probiotics - Market size and forecast 2022-2027
• Exhibit 47: Chart on Probiotics - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Probiotics - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Probiotics - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Probiotics - Year-over-year growth 2022-2027 (%)

• 7.4 Foods - Market size and forecast 2022-2027
• Exhibit 51: Chart on Foods - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Foods - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Foods - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Foods - Year-over-year growth 2022-2027 (%)

• 7.5 Prebiotics - Market size and forecast 2022-2027
• Exhibit 55: Chart on Prebiotics - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Prebiotics - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Prebiotics - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Prebiotics - Year-over-year growth 2022-2027 (%)

• 7.6 Medical food - Market size and forecast 2022-2027
• Exhibit 59: Chart on Medical food - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Medical food - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Medical food - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Medical food - Year-over-year growth 2022-2027 (%)

• 7.7 Others - Market size and forecast 2022-2027
• Exhibit 63: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.8 Market opportunity by Product 
• Exhibit 67: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 69: Chart on Market share by geography 2022-2027 (%)
• Exhibit 70: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 France - Market size and forecast 2022-2027
• Exhibit 97: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.10 Japan - Market size and forecast 2022-2027
• Exhibit 101: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 105: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 4D pharma Plc 
• Exhibit 116: 4D pharma Plc - Overview
• Exhibit 117: 4D pharma Plc - Product / Service
• Exhibit 118: 4D pharma Plc - Key offerings

• 12.4 AOBiome LLC 
• Exhibit 119: AOBiome LLC - Overview
• Exhibit 120: AOBiome LLC - Product / Service
• Exhibit 121: AOBiome LLC - Key offerings

• 12.5 BiomX Inc. 
• Exhibit 122: BiomX Inc. - Overview
• Exhibit 123: BiomX Inc. - Product / Service
• Exhibit 124: BiomX Inc. - Key offerings

• 12.6 DuPont de Nemours Inc. 
• Exhibit 125: DuPont de Nemours Inc. - Overview
• Exhibit 126: DuPont de Nemours Inc. - Business segments
• Exhibit 127: DuPont de Nemours Inc. - Key news
• Exhibit 128: DuPont de Nemours Inc. - Key offerings
• Exhibit 129: DuPont de Nemours Inc. - Segment focus

• 12.7 Eligo Bioscience 
• Exhibit 130: Eligo Bioscience - Overview
• Exhibit 131: Eligo Bioscience - Product / Service
• Exhibit 132: Eligo Bioscience - Key offerings

• 12.8 ENTEROME SA 
• Exhibit 133: ENTEROME SA - Overview
• Exhibit 134: ENTEROME SA - Product / Service
• Exhibit 135: ENTEROME SA - Key offerings

• 12.9 Evelo Biosciences Inc. 
• Exhibit 136: Evelo Biosciences Inc. - Overview
• Exhibit 137: Evelo Biosciences Inc. - Product / Service
• Exhibit 138: Evelo Biosciences Inc. - Key offerings

• 12.10 ExeGi Pharma 
• Exhibit 139: ExeGi Pharma - Overview
• Exhibit 140: ExeGi Pharma - Product / Service
• Exhibit 141: ExeGi Pharma - Key offerings

• 12.11 Ferring BV 
• Exhibit 142: Ferring BV - Overview
• Exhibit 143: Ferring BV - Product / Service
• Exhibit 144: Ferring BV - Key offerings

• 12.12 Osel Inc. 
• Exhibit 145: Osel Inc. - Overview
• Exhibit 146: Osel Inc. - Product / Service
• Exhibit 147: Osel Inc. - Key offerings

• 12.13 PureTech Health Plc 
• Exhibit 148: PureTech Health Plc - Overview
• Exhibit 149: PureTech Health Plc - Business segments
• Exhibit 150: PureTech Health Plc - Key offerings
• Exhibit 151: PureTech Health Plc - Segment focus

• 12.14 Second Genome Therapeutics 
• Exhibit 152: Second Genome Therapeutics - Overview
• Exhibit 153: Second Genome Therapeutics - Product / Service
• Exhibit 154: Second Genome Therapeutics - Key offerings

• 12.15 Seres Therapeutics Inc. 
• Exhibit 155: Seres Therapeutics Inc. - Overview
• Exhibit 156: Seres Therapeutics Inc. - Product / Service
• Exhibit 157: Seres Therapeutics Inc. - Key offerings

• 12.16 Synlogic Inc. 
• Exhibit 158: Synlogic Inc. - Overview
• Exhibit 159: Synlogic Inc. - Product / Service
• Exhibit 160: Synlogic Inc. - Key offerings

• 12.17 Synthetic Biologics Inc. 
• Exhibit 161: Synthetic Biologics Inc. - Overview
• Exhibit 162: Synthetic Biologics Inc. - Product / Service
• Exhibit 163: Synthetic Biologics Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 166: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources

• 13.5 List of abbreviations 
• Exhibit 170: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports, covering 800 technologies spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio